Plasma Cells in Health and Disease
Plasma Cells in Health and Disease
批准号:
10428164
负责人:
Ignacio E. Sanz
金额:
$269.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-06-25 至 2027-04-30
关键词:
AcuteAddressAllergic ReactionAnimalsAntibodiesAntigensAreaAutoimmune DiseasesAutoimmune ResponsesB-LymphocytesBioinformaticsBiological Response Modifier TherapyBone MarrowCOVID-19 pandemicCRISPR/Cas technologyCell AgingCell CompartmentationCell Differentiation processCell MaturationCell SurvivalCell physiologyCellsChromatinComplementary DNAComputer AnalysisDNA MethylationData SetDevelopmentDiseaseEZH2 geneEnsureEpigenetic ProcessFoundationsGenerationsGenetic TranscriptionGenome engineeringGoalsGraft RejectionHealthHeme IronHeterogeneityHumanHypersensitivityImmune systemImmunoglobulin AImmunoglobulin GImmunoglobulin MImmunoglobulin-Secreting CellsInfectionInformation DisseminationInvestigationLaboratory PersonnelLibrariesLifeLongevityMediatingMemoryMemory B-LymphocyteMetabolicMetabolismMolecularNaturePathogenicityPathway interactionsPlasma CellsPlasmablastPopulationPreparationProcessProductionRegulationResearch PersonnelRoleSIRT1 geneSafetySerologySystemic Lupus ErythematosusTimeTranscriptional RegulationVaccinationWorkarmautoreactivitybasedata sharingdesigneffective therapyepigenetic regulationepigenomicshistone modificationhuman tissueimmune functionimmunogenicimprovedmethylation patternoverexpressionprogramsresponsetranscriptomevaccine response
中文摘要
抗体分泌细胞(ASC)负责保护性和致病性反应
通过被赋予不同功能和寿命的人口的功能。因此,少校
人类健康和疾病方面未得到满足的需求是深刻理解
通过不同的分化途径从不同的B细胞前体产生ASC;
代谢,转录和表观遗传程序,支持这些过程,从而
促进不同寿命和功能的不同ASC群体的产生;以及如何
这些过程在SLE中可能被破坏,导致致病性自身反应性免疫缺陷的扩大,
浆细胞适当的ASC功能和失调分别提供保护,
接种疫苗和感染并介导多种疾病,包括SLE和其他自身免疫性疾病
条件,过敏反应和移植排斥反应。因此,了解
调节保护性ASC的分化和存活,同时避免
致病性病毒对我们提高疫苗接种和治疗多种抗体的能力至关重要,
介导的疾病。
在上一个周期,尽管2019冠状病毒病大流行造成严重干扰,
一年多来,我们的工作在这些领域取得了重大进展,
对于这个更新的应用程序。结合起来,我们的工作将涉及以下概念:
人类健康和自身免疫反应中的ASC异质性;主题2 -分子和
PC发育和存活的表观遗传调节;主题3 -ASC的代谢调节
分化、功能和存活;主题4:ASC形成的微环境调节,
生存和功能。这些目标将由高度互动的调查人员通过以下方式实现:
以下项目和核心:
项目1。决定长寿承诺的表观遗传和代谢机制
浆细胞池(隆德,PI)。
项目2.浆细胞异质性和代谢的表观遗传程序。(Boss、PI)
项目3。细胞衰老在长寿命浆细胞生成中的作用。(Lee、PI)
项目4。异源SLE中抗体分泌细胞的调节和功能(Sanz,PI)
核心A。行政核心(Sanz,PI)
核心B。表观基因组学,生物信息学和基因组工程(Scharer,PI)
英文摘要
Antibody secreting cells (ASC) are responsible for both protective and pathogenic responses
through the function of populations endowed with different function and longevity. Hence, major
unmet need in human health and disease is a deep understanding of the processes that underlie
ASC generation from different B cell precursors through separate differentiation pathways; the
metabolic, transcriptional and epigenetic programs that underpin these processes, thereby
promoting the generation of diverse ASC populations of different longevity and function; and how
these processes may be subverted in SLE leading to expansion of pathogenic autoreactive
plasma cells. Proper ASC function and dysregulation respectively provide protection in
vaccination and infection and mediate multiple diseases including SLE and other autoimmune
conditions, allergic reactions and transplant rejection. Thus, understanding the processes that
regulate differentiation and survival of protective ASC while avoiding the accumulation of
pathogenic ones is essential for our ability to improve vaccination and treat multiple antibody-
mediated diseases.
Over the previous cycle, despite the severe disruption caused by the COVID-19 pandemic for
over a year, our work has contributed major progress in these areas that provides the foundation
for this renewal application. Combined, our work will address the following concepts: Theme 1 -
ASC heterogeneity in human healthy and autoimmune responses; Theme 2 - Molecular and
epigenetic regulation of PC development and survival; Theme 3 - Metabolic regulation of ASC
differentiation, function and survival; Theme 4: Microenvironment regulation of ASC formation,
survival and function. These goals will be accomplished by highly interactive investigators through
the following Projects and cores:
Project 1. Epigenetic and metabolic mechanisms governing commitment to the long-lived
plasma cell pool (Lund, PI).
Project 2. Epigenetic programming of plasma cell heterogeneity and metabolism. (Boss, PI)
Project 3. Role of Cellular Senescence in long-lived plasma cell generation. (Lee, PI)
Project 4. Heterogeneity. Regulation and Function of Antibody-Secreting Cells in SLE (Sanz, PI)
Core A. Administrative Core (Sanz, PI)
Core B. Epigenomics, Bioinformatics, and Genome Engineering (Scharer, PI)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10493525
-
项目类别:
-
资助金额:$8.88万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
ACE Funds Management Core
-
批准号:10439991
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
ACE Covid 19 Admin Supplement: Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10456447
-
项目类别:
-
资助金额:$2679.42万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10439989
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2021
-
负责人:Ignacio E. Sanz
-
依托单位:
Administrative Supplement Covid19: Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10164943
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10265747
-
项目类别:
-
资助金额:$37.47万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680628
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10680631
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222317
-
项目类别:
-
资助金额:$31.82万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Regulation of Pathogenic Plasma Cells in Human SLE
-
批准号:10187509
-
项目类别:
-
资助金额:$174.78万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Principal Project
-
批准号:10198495
-
项目类别:
-
资助金额:$52.56万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10222320
-
项目类别:
-
资助金额:$79.55万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Project-002
-
批准号:10441807
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Molecular Regulation of B cells and T cells in Human SLE
-
批准号:10265746
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
-
批准号:10710093
-
项目类别:
-
资助金额:$54.51万
-
财政年份:2020
-
负责人:Ignacio E. Sanz
-
依托单位:
Plasma Cells in Health and Disease
-
批准号:10621320
-
项目类别:
-
资助金额:$269.13万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Project 1
-
批准号:10428167
-
项目类别:
-
资助金额:$55.02万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Project 4
-
批准号:10428170
-
项目类别:
-
资助金额:$54.2万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Administrative Core
-
批准号:10428165
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
Administrative Core
-
批准号:10621322
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2016
-
负责人:Ignacio E. Sanz
-
依托单位:
海外基金